Am. J. Respir. Crit. Care Med., Vol 152, No. 6, Dec 1995, 2127-2132.
Excessive neutrophil elastase in bronchoalveolar lavage fluid in subclinical emphysema
A Yoshioka, T Betsuyaku, M Nishimura, K Miyamoto, T Kondo and Y Kawakami
First Department of Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
In an attempt to further evaluate the role of neutrophil elastase (NE) in
the development of emphysema, we examined the immunologic quantity of NE
bound to alpha 1-protease inhibitor (PI), the NE inhibitory activity, and
the molecular pattern of alpha 1-PI in unconcentrated bronchoalveolar
lavage fluid (BALF) supernatant from 36 community-based older volunteers.
They were classified into three groups: 10 current smokers with low
attenuation areas (LAAs) on the lung computed tomography (CT) scans who
were considered to have subclinical emphysema, 13 current smokers who had a
comparable smoking history but no LAA, and 13 noncurrent smokers without
LAA. The concentration of NE- alpha 1-PI complex was significantly
increased in the subjects with subclinical emphysema when compared not only
with the noncurrent smokers (0.52 +/- 0.10 versus 0.21 +/- 0.03 SEM
micrograms/mg albumin, p < 0.01) but also with the LAA(-) current
smokers (0.52 +/- 0.10 versus 0.23 +/- 0.07 SEM micrograms/mg albumin, p
< 0.01). NE inhibitory activity measured by a spectrophotometric method
using methoxysuccinyl-alanyl-alanyl-prolyl-valyl-paranitroanilide did not
show any significant difference between the two groups of current smokers.
There was no difference in the pattern or density of native and proteolysed
alpha 1-PI bands between the three groups by Western blotting. We conclude
that NE-alpha 1-PI complex in BALF is a factor that may differentiate
smokers who are potentially developing emphysema from those who are not.
This article has been cited by other articles:

|
 |

|
 |
 
H. Makita, Y. Nasuhara, K. Nagai, Y. Ito, M. Hasegawa, T. Betsuyaku, Y. Onodera, N. Hizawa, M. Nishimura, and the Hokkaido COPD Cohort Study Group
Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease
Thorax,
November 1, 2007;
62(11):
932 - 937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hasegawa, Y. Nasuhara, Y. Onodera, H. Makita, K. Nagai, S. Fuke, Y. Ito, T. Betsuyaku, and M. Nishimura
Airflow Limitation and Airway Dimensions in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
June 15, 2006;
173(12):
1309 - 1315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Nagai, T Betsuyaku, T Kondo, Y Nasuhara, and M Nishimura
Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid
Thorax,
June 1, 2006;
61(6):
496 - 502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R O'Donnell, D Breen, S Wilson, and R Djukanovic
Inflammatory cells in the airways in COPD
Thorax,
May 1, 2006;
61(5):
448 - 454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Betsuyaku, Y. Kuroki, K. Nagai, Y. Nasuhara, and M. Nishimura
Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid
Eur. Respir. J.,
December 1, 2004;
24(6):
964 - 970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes
Mediators of Chronic Obstructive Pulmonary Disease
Pharmacol. Rev.,
December 1, 2004;
56(4):
515 - 548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fuke, T. Betsuyaku, Y. Nasuhara, T. Morikawa, H. Katoh, and M. Nishimura
Chemokines in Bronchiolar Epithelium in the Development of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Cell Mol. Biol.,
October 1, 2004;
31(4):
405 - 412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. T. Spencer, G. Paone, P. M. Krein, F. N. Rouhani, J. Rivera-Nieves, and M. L. Brantly
Role of human neutrophil peptides in lung inflammation associated with {alpha}1-antitrypsin deficiency
Am J Physiol Lung Cell Mol Physiol,
March 1, 2004;
286(3):
L514 - L520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Betsuyaku, M. Tanino, K. Nagai, Y. Nasuhara, M. Nishimura, and R. M. Senior
Extracellular Matrix Metalloproteinase Inducer Is Increased in Smokers' Bronchoalveolar Lavage Fluid
Am. J. Respir. Crit. Care Med.,
July 15, 2003;
168(2):
222 - 227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kuraki, M. Ishibashi, M. Takayama, M. Shiraishi, and M. Yoshida
A Novel Oral Neutrophil Elastase Inhibitor (ONO-6818) Inhibits Human Neutrophil Elastase-induced Emphysema in Rats
Am. J. Respir. Crit. Care Med.,
August 15, 2002;
166(4):
496 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Betsuyaku, K. Takeyabu, M. Tanino, and M. Nishimura
Role of secretory leukocyte protease inhibitor in the development of subclinical emphysema
Eur. Respir. J.,
June 1, 2002;
19(6):
1050 - 1057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Tanino, T Betsuyaku, K Takeyabu, Y Tanino, E Yamaguchi, K Miyamoto, and M Nishimura
Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema
Thorax,
May 1, 2002;
57(5):
405 - 411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes
Chronic Obstructive Pulmonary Disease
N. Engl. J. Med.,
July 27, 2000;
343(4):
269 - 280.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nishimura, T. Betsuyaku, M. Tanino, K. Takeyabu, K. Miyamoto, and Y. Kawakami
Proteases and Chemotactic Factors in BAL Fluid From Subjects With Subclinical Emphysema
Chest,
May 1, 2000;
117(5_suppl_1):
282S - 282S.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Betsuyaku, M. Nishimura, K. Takeyabu, M. Tanino, P. Venge, S. Xu, and Y. Kawakami
Evidence for Neutrophil Involvement in the Development of Subclinical Emphysema
Chest,
May 1, 2000;
117(5_suppl_1):
302S - 303S.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. KOHLHÄUFL, P. BRAND, C. ROCK, T. RADONS, G. SCHEUCH, T. MEYER, H. SCHULZ, K. J. PFEIFER, K. HÄUSSINGER, and J. HEYDER
Noninvasive Diagnosis of Emphysema . Aerosol Morphometry and Aerosol Bolus Dispersion in Comparison to HRCT
Am. J. Respir. Crit. Care Med.,
September 1, 1999;
160(3):
913 - 918.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. BETSUYAKU, M. NISHIMURA, K. TAKEYABU, M. TANINO, P. VENGE, S. XU, and Y. KAWAKAMI
Neutrophil Granule Proteins in Bronchoalveolar Lavage Fluid from Subjects with Subclinical Emphysema
Am. J. Respir. Crit. Care Med.,
June 1, 1999;
159(6):
1985 - 1991.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Fujimoto, K. Kubo, H. Yamamoto, S. Yamaguchi, and Y. Matsuzawa
Eosinophilic Inflammation in the Airway Is Related to Glucocorticoid Reversibility in Patients With Pulmonary Emphysema
Chest,
March 1, 1999;
115(3):
697 - 702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. FINLAY, L. R. O'DRISCOLL, K. J. RUSSELL, E. M. D'ARCY, J. B. MASTERSON, M. X. FITZGERALD, and C. M. O'CONNOR
Matrix Metalloproteinase Expression and Production by Alveolar Macrophages in Emphysema
Am. J. Respir. Crit. Care Med.,
July 1, 1997;
156(1):
240 - 247.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1995 American Thoracic Society
|
|
|